Technology | February 18, 2009

February 19, 2009 -Varian Medical Systems today announced that it has received CE mark for the Varian Proton Therapy System, a system that enables the use of higher doses of radiation to control and manage tumors while significantly reducing damage to healthy tissue and vital organs.

The CE mark makes it possible for cancer treatment centers to begin ordering, installing and using the Varian Proton Therapy System in regions where CE mark is required without having to obtain a site-specific clearance to use this important technology.

“Varian is actively marketing the Varian Proton Therapy System, and institutions from all parts of the world are pursuing this promising technology for cancer patients in their regions,” Boeh said.

Through research and development and the acquisition of ACCEL in Germany during 2007, Varian has developed a comprehensive proton therapy system that utilizes the company's technology for particle beam generation, treatment planning, imaging, motion management, and information management technology.

For more information: www.varian.com


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now